Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/5499
Title: Citalopram-induced photopigmentation
Authors: I°nalöz, H.S.
Kirtak, N.
Herken, H.
Özgöztaşi, O.
Aynacıoğlu, Ahmet Şükrü
Keywords: Adverse event
Citalopram
Photopigmentation
amitriptyline
citalopram
cyclophosphamide
cytochrome P450 3A4
diazepam
mephenytoin
moclobemide
omeprazole
proguanil
serotonin uptake inhibitor
adult
article
case report
clinical feature
depression
drug induced disease
drug metabolism
female
genetic polymorphism
human
hyperpigmentation
skin manifestation
treatment outcome
Depression
Diagnosis, Differential
Face
Female
Forearm
Humans
Hyperpigmentation
Middle Aged
Neck
Photosensitivity Disorders
Serotonin Uptake Inhibitors
Abstract: Citalopram is one of the newer and most potent selective serotonin re-uptake inhibitor (SSRI) drugs. It has a well-established antidepressive action with a favorable adverse event profile. We present a fifty-year-old woman with diffuse photopigmentation who had been diagnosed as suffering from depression. The patient was given citalopram (40 mg/day) for her psychiatric condition and diffuse photopigmentation was noted thereafter. To our knowledge, such an adverse event has not been reported previously.
URI: https://hdl.handle.net/11499/5499
https://doi.org/10.1111/j.1346-8138.2001.tb00070.x
ISSN: 0385-2407
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

SCOPUSTM   
Citations

16
checked on Sep 30, 2024

WEB OF SCIENCETM
Citations

9
checked on Sep 24, 2024

Page view(s)

36
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.